Argatra Multidose (Argatroban Monohydrate)

Argatra Multidose is an intravenous medication containing Argatroban Monohydrate, used for anticoagulation therapy. This product is manufactured by Ethypharm and is suitable for hospital settings.

Argatra Multidose is primarily used for anticoagulation in patients undergoing procedures like percutaneous coronary intervention (PCI) or those with heparin-induced thrombocytopenia (HIT). It works by inhibiting thrombin, a key enzyme in blood clotting. This medication is often used in hospital settings where close monitoring of blood clotting is necessary.

Common effects of Argatraban Monohydrate may include bleeding at the injection site or prolonged clotting times. Patients should be monitored regularly to ensure the medication is working as intended. Any unusual bleeding or bruising should be reported to a healthcare provider.

Argatra Multidose should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of infection. Patients with a history of bleeding disorders or recent surgery should use this medication under close supervision.

Argatra Multidose may interact with other anticoagulants, antiplatelet drugs, or medications that affect blood clotting. Alcohol and certain supplements may also influence its effectiveness. Always inform your healthcare provider about all medications you are taking.